Statins and sepsis: multiple modifications at multiple levels. (Q36797719)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Statins and sepsis: multiple modifications at multiple levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Yaniv Almog

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Robert S Rosenson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Terry S Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Daniel G Hackam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

1 reference

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

358-368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

Sepsis: current status, future prospects

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Long-term mortality and medical care charges in patients with severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statins, inflammation, and sepsis: hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Role of NFkappaB in the mortality of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

The sirens' songs of confirmatory sepsis trials: selection bias and sampling error.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statins: panacea for sepsis?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statin use and mortality within 180 days after bacteremia: A population-based cohort study*

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statin therapy is associated with fewer deaths in patients with bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

HMG-CoA reductase inhibitors induce COX-2 gene expression in murine macrophages: role of MAPK cascades and promoter elements for CREB and C/EBPbeta.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statins upregulate CD36 expression in human monocytes, an effect strengthened when combined with PPAR-gamma ligands Putative contribution of Rho GTPases in statin-induced CD36 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Inhibition of proinflammatory cytokine production by pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Simvastatin prevents vascular hyporeactivity during inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Simvastatin blunts endotoxin-induced tissue factor in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Inhibition of monocyte chemotactic protein-1 synthesis by statins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Lovastatin induces differentiation of Mono Mac 6 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statin-induced immunomodulatory effects on human T cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Superoxide anion overproduction in sepsis: effects of vitamin e and simvastatin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statin therapy: new therapy for cardiac microvascular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

NF-kappaB regulation in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Nuclear factor-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Mitogen-activated protein kinase (MAPK).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Calcium/calmodulin-dependent kinase II is required for platelet-activating factor priming.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Akt signaling: linking membrane events to life and death decisions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Akt is more than just a Bad kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Akt/protein kinase B.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Cellular survival: a play in three Akts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Phosphoinositide 3-kinase and Akt occupy central roles in inflammatory responses of Toll-like receptor 2-stimulated neutrophils.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

1 reference

7 January 2021

Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

C-reactive protein levels correlate with mortality and organ failure in critically ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Effects of statins on C-reactive protein and interleukin-6 (the Ludwigshafen Risk and Cardiovascular Health study).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statins and the acute-phase response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Bench-to-bedside review: microvascular dysfunction in sepsis--hemodynamics, oxygen transport, and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Nitric oxide: a clinical primer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Glaxo Wellcome International Septic Shock Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

1 reference

7 January 2021

Coagulation in severe sepsis: a central role for thrombomodulin and activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

The effect of statins on mortality in patients with bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Cellular antioxidant effects of atorvastatin in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Carbon monoxide inhibits human airway smooth muscle cell proliferation via mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Heme oxygenase-1: from bench to bedside

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Effect of serum albumin and bilirubin on the risk of myocardial infarction (the Framingham Offspring Study)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Bilirubin and ascorbate antioxidant activity in neonatal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Lymphocyte function antigen-1 mediates leukocyte adhesion and subsequent liver damage in endotoxemic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statins inhibit HIV-1 infection by down-regulating Rho activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statins as a newly recognized type of immunomodulator

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statin treatment after onset of sepsis in a murine model improves survival

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statins, bugs and prophylaxis: intriguing possibilities.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Statins in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Pandemic influenza: a potential role for statins in treatment and prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

Vaccine development for an imminent pandemic: why we should worry, what we must do.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970111-1

7 January 2021

10.1016/S1473-3099(07)70111-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448939%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference